Induction of apoptosis in K562 human leukemia cells by 2â²,4â²-dihydroxy-6â²-methoxy-3â²,5â²-dimethylchalcone Fulltext Access 6 Pages 2005
Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells Fulltext Access 6 Pages 2005
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer Fulltext Access 6 Pages 2005
Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers Fulltext Access 6 Pages 2005
Effectiveness of transbronchial needle aspiration in the diagnosis of exophytic endobronchial lesions and submucosal/peribronchial diseases of the lung Fulltext Access 6 Pages 2005
Normal neutrophil maturation is associated with selective loss of MAP kinase activation by G-CSF Fulltext Access 6 Pages 2005
Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignancies Fulltext Access 6 Pages 2005
Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis Fulltext Access 6 Pages 2005
Myelodysplastic syndromes in patients under 50 years old: a single institution experience Fulltext Access 6 Pages 2005
Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation Fulltext Access 6 Pages 2005
Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients Fulltext Access 6 Pages 2005
Treatment of elderly patients with acute lymphoblastic leukemia-Evidence for a benefit of imatinib in BCR-ABL positive patients Fulltext Access 6 Pages 2005
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation Fulltext Access 6 Pages 2005
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956) Fulltext Access 6 Pages 2005
Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis Fulltext Access 6 Pages 2005
Expression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-α Fulltext Access 6 Pages 2005
Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia Fulltext Access 6 Pages 2005
The peripheral blood Vα24+NKT cell numbers decrease in patients with haematopoietic malignancy Fulltext Access 6 Pages 2005
Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor Fulltext Access 6 Pages 2005
Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma Fulltext Access 6 Pages 2005
A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals Fulltext Access 6 Pages 2005
Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia Fulltext Access 6 Pages 2005
Proliferation and apoptosis in the corneal stroma in longterm follow-up after photorefractive keratectomy Fulltext Access 6 Pages 2005
Aspects of oxalosis associated with aspergillosis in pathology specimens Fulltext Access 6 Pages 2005
Synchronous CIN 3 and cervical lymphoma: a case report and review of the literature Fulltext Access 6 Pages 2005
Prognostic importance of COX-2 expression in patients with colorectal cancer Fulltext Access 6 Pages 2005
Soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions Fulltext Access 6 Pages 2005
Endometrial carcinoma metastatic to the vulva: A case report and review of the literature Fulltext Access 6 Pages 2005
Effects of exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis fungus on c-Myc, c-Fos, and VEGF expression in B16 melanoma-bearing mice Fulltext Access 6 Pages 2005
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia Fulltext Access 6 Pages 2005
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials Fulltext Access 6 Pages 2005
Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial Fulltext Access 6 Pages 2005
The role of PET in the surgical management of malignant pleural mesothelioma Fulltext Access 6 Pages 2005
Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis Fulltext Access 6 Pages 2005
Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel Fulltext Access 6 Pages 2005
Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients Fulltext Access 6 Pages 2005
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC) Fulltext Access 6 Pages 2005
Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex Fulltext Access 6 Pages 2005
Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study Fulltext Access 6 Pages 2005
Use of Upper Limb Exercise to Assess Breathlessness in Patients with Cancer: Tolerability, Repeatability, and Sensitivity Fulltext Access 6 Pages 2005
Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases Fulltext Access 6 Pages 2005
Personal Values and Individual Quality of Life in Palliative Care Patients Fulltext Access 6 Pages 2005
Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates-The Massachusetts General Hospital and Radiation Therapy Oncology Group experiences Fulltext Access 6 Pages 2005
Palliation of Bone Pain in Prostate Cancer Using Chemotherapy and Strontium-89. A Randomized Phase II Study Fulltext Access 6 Pages 2005
Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer Fulltext Access 6 Pages 2005
Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation Fulltext Access 6 Pages 2005
Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells Fulltext Access 6 Pages 2005
Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations Fulltext Access 6 Pages 2005
The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy Fulltext Access 6 Pages 2005
The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma Fulltext Access 6 Pages 2005
Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications Fulltext Access 6 Pages 2005
Activation of the coagulation system in cancerogenesis and metastasation Fulltext Access 6 Pages 2005
Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells Fulltext Access 6 Pages 2005
Renal epithelioid angiomyolipoma-a close mimic of renal cell carcinoma. Report of a case and review of the literature Fulltext Access 6 Pages 2005
A case report of dystrophic localized amyloidosis that developed in the left thigh Fulltext Access 6 Pages 2005
Vascular endothelial growth factor expression in untreated and androgen-deprived patients with prostate cancer Fulltext Access 6 Pages 2005
Evaluation of nucleolar organizer region (NOR) parameters in the uterine leiomyoma Fulltext Access 6 Pages 2005
S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma Fulltext Access 6 Pages 2005
Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: A possible interaction with polymorphisms in the interleukin 1 beta gene Fulltext Access 6 Pages 2005
A Molecular/Epidemiologic Analysis of Expression of Cyclooxygenases 1 and 2,Use of Nonsteroidal Antiinflammatory Drugs, and Risk of Colorectal Adenoma Fulltext Access 6 Pages 2005
Two Consecutive Phase II Trials of Biweekly Oxaliplatin plus Weekly 48-Hour Continuous Infusion of Nonmodulated High-Dose 5-Fluorouracil as First-Line Treatment for Advanced Colorectal Cancer Fulltext Access 6 Pages 2005
Analysis of Prognostic Factors and Applicability of Köhne's Prognostic Groups in Patients with Metastatic Colorectal Cancer Treated with First-Line Irinotecan or Oxaliplatin-Based Chemotherapy Fulltext Access 6 Pages 2005
Differential modulation of normal and tumor cell proliferation by reactive oxygen species Fulltext Access 6 Pages 2005
Contemporary Applications of Transanal Endoscopic Microsurgery: Technical Innovations and Limitations Fulltext Access 6 Pages 2005
Phase I/II Dose-Escalation Study of Pemetrexed plus Irinotecan in Patients with Advanced Colorectal Cancer Fulltext Access 6 Pages 2005
Highlights From: The 4th International Congress on Colorectal Cancer; Aventura, Florida, October 2005 Fulltext Access 6 Pages 2005
Changing Patterns of Bone and Brain Metastases in Patients with Colorectal Cancer Fulltext Access 6 Pages 2005
Management of Rash and Other Toxicities in Patients Treated with Epidermal Growth Factor Receptor-Targeted Agents Fulltext Access 6 Pages 2005
A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane Fulltext Access 6 Pages 2005
Effectiveness and Tolerability of Fulvestrant in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer Fulltext Access 6 Pages 2005
Single-Agent Topotecan as First-Line Chemotherapy in Women with Metastatic Breast Cancer: Final Results of Eastern Cooperative Oncology Group Trial E8193 Fulltext Access 6 Pages 2005
Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial Fulltext Access 6 Pages 2005
Final Results of a Phase II Trial of Preoperative TAC (Docetaxel/Doxorubicin/Cyclophosphamide) in Stage III Breast Cancer Fulltext Access 6 Pages 2005